substance p has been researched along with Cardiac Hypertrophy in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brower, GL; Janicki, JS; Levick, SP; Murray, DB | 1 |
| BUSCH, E | 1 |
| D'Souza, M; Garza, MA; Robinson, P; Weinstock, J; Xiang, Q; Xie, M | 1 |
| Lai, YL; Zhou, KR | 1 |
4 other study(ies) available for substance p and Cardiac Hypertrophy
| Article | Year |
|---|---|
Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart.
Topics: Analysis of Variance; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Hypertension; Inflammation Mediators; Male; Myocytes, Cardiac; Probability; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Substance P; Sympathectomy; Sympathetic Nervous System; Ventricular Remodeling | 2010 |
[Anaphylaxis-conditioned circulatory disorders in the rabbit heart and its modification by the coronary dilator substance 1-p-ethoxyphenyl-3-diethylaminoindane].
Topics: Anaphylaxis; Animals; Cardiomegaly; Coronary Vessels; Heart; Hypersensitivity; Rabbits; Substance P | 1962 |
Substance P is associated with heart enlargement and apoptosis in murine dilated cardiomyopathy induced by Taenia crassiceps infection.
Topics: Animals; Apoptosis; Cardiomegaly; Cardiomyopathy, Dilated; Cysticercosis; Disease Models, Animal; Female; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Neurotransmitter Agents; Substance P; Taenia; Taeniasis | 2007 |
Capsaicin pretreatment attenuates monocrotaline-induced ventilatory dysfunction and pulmonary hypertension.
Topics: Animals; Blood Pressure; Body Weight; Capsaicin; Cardiomegaly; Endopeptidases; Hypertension, Pulmonary; Monocrotaline; Nerve Fibers; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Respiratory Function Tests; Respiratory Tract Diseases; Substance P | 1993 |